SCHEMBL9533735

SCHEMBL9533735

O=C1N(c2cccc(Cl)c2)c2ncccc2C(O)C12CCCCO2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.36
MAPT P10636 4/20 0.35
POLB P06746 2/20 0.35
KDM4E B2RXH2 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ALDH1A1 P00352 5/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MEN1 O00255 5/20 0.35
KMT2A Q03164 5/20 0.35
CYP2C19 P33261 2/20 0.35
ALOX15 P16050 2/20 0.34
TSHR P16473 2/20 0.34
HSP90AA1 P07900 1/20 0.33
CYP1A2 P05177 1/20 0.32
HPGD P15428 1/20 0.32
MGLL Q99685 1/20 0.32
MALT1 Q9UDY8 1/20 0.32
GFER P55789 1/20 0.32
PKM P14618 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9533850 0.89 ALDH1A1 (0.33) LMNAALDH1A1MAPK1
SCHEMBL9536299 0.83 MAPT (0.39) LMNAMAPTPOLBKDM4EL3MBTL1
SCHEMBL9629185 0.75 PGR (0.36) LMNAMAPTPOLBKDM4EL3MBTL1
SCHEMBL9767569 0.71 ALDH1A1 (0.37) LMNAALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL9352368 0.69 PGR (0.42) MAPTPOLBKDM4EL3MBTL1NPSR1
SCHEMBL9767646 0.65 ALDH1A1 (0.34) LMNAPOLBALDH1A1MEN1KMT2A
SCHEMBL9469933 0.65 PGR (0.60) MAPTPOLBKDM4EL3MBTL1NPSR1
SCHEMBL9537511 0.64 PGR (0.41) MAPTALDH1A1MEN1KMT2AHPGD
SCHEMBL9628950 0.63 MAPT (0.38) MAPTKDM4EL3MBTL1ALDH1A1MEN1
SCHEMBL9469283 0.62 ALDH1A1 (0.39) LMNAMAPTPOLBKDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0241291-B1 ARYL-SUBSTITUTED NAPHTHYRIDINE AND PYRIDOPYRAZINE DERIVATIVES SCHERING CORPORATION (US) 1993-06-02 EP disclosed
US-5045542-A Immune suppression method employing aryl-substituted naphthyridine and pyridopyrazine derivatives SCHERING CORPORATION (US) 1991-09-03 US disclosed
US-5011860-A Aryl-substituted naphthyridine and pyridopyrazine derivatives and their use in treating hyperproliferative skin diseases SCHERING CORPORATION (US) 1991-04-30 US disclosed
US-4882332-A Immune suppression method employing arly-substituted naphthyridine and pyridopyrazine derivatives SCHERING CORPORATION (US) 1989-11-21 US disclosed
US-4866061-A TREATMENT OF ALLERGIC REACTIONS, ULCERS, INFLAMMATION SCHERING CORPORATION (US) 1989-09-12 US disclosed
US-4760073-A Aryl-substituted naphthyridine and pyridopyrazine derivatives, useful as anti-allergic agents SCHERING CORPORATION (US) 1988-07-26 US disclosed
EP-0241291-A2 Aryl-substituted naphthyridine and pyridopyrazine derivatives SCHERING CORPORATION (US) 1987-10-14 EP disclosed